Why the study?
The COVID-19 pandemic modified practice for symptomatic aortic stenosis, risking higher mortality from treatment delays, prompting evaluation of ambulatory TAVR feasibility.
Case Report (n=3)
Ambulatory TAVR using a minimalist approach is feasible in carefully selected patients with symptomatic aortic stenosis, which may help conserve hospital resources during the COVID-19 pandemic.
Answers are grounded in this paper and cite their sources.
May support ambulatory TAVR in selected patients; leaves open safety and scalability beyond this case series.
The COVID-19 pandemic has modified practice for patients with symptomatic aortic stenosis and could result in higher mortality rates due to treatment delays. In this clinical case series, 3 patients underwent ambulatory transcatheter aortic valve replacement (TAVR) thanks to patient and entourage willingness, careful patient selection (including a history of permanent pacemaker placement), and a minimalist procedural approach. No complications occurred during the 30-day follow-up. Performing ambulatory TAVR could reduce the clinical consequences of wait times, minimize exposure to coronavirus contamination, and reduce the use of hospital resources that might be needed for COVID-19 patients. Thanks to a scrupulous minimalist TAVR protocol, ambulatory outpatient management of aortic stenosis was possible in the context of the COVID-19 pandemic.
No takes yet. Share an insight, caveat, or question.
Zouaghi et al. (2020) conducted a case report in Symptomatic aortic stenosis (n=3). Ambulatory transcatheter aortic valve replacement (TAVR) was evaluated on Complications.
Synapse has enriched 10 related papers. Consider them for comparative context: